Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Ansul** is a transliteration used for **安素**, the Chinese trade name for **Ensure**, an Abbott enteral nutritional powder product whose approved generic name is enteral nutritional powder (TP). It is a complete, polymeric nutritional formula containing protein, fat, carbohydrate, vitamins, and minerals; it supplies nutrition through gastrointestinal digestion and absorption rather than by pharmacologic binding to a molecular target. The Chinese product label states that it may be used as complete nutritional support or as a nutritional supplement in adults and children aged 4 years or older, administered orally or by feeding tube, and must not be administered parenterally or intravenously. ([abbott.com.cn](https://www.abbott.com.cn/content/dam/corp/abbott/cn-cn/2026_update/%E5%AE%89%E7%B4%A0%E8%AF%B4%E6%98%8E%E4%B9%A6-20251201.pdf))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on enteral nutritional powder (TP).